| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.
|
Am J Epidemiol
|
2005
|
6.20
|
|
2
|
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.
|
N Engl J Med
|
2002
|
4.07
|
|
3
|
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.
|
Circulation
|
2003
|
2.73
|
|
4
|
Aprotinin during coronary-artery bypass grafting and risk of death.
|
N Engl J Med
|
2008
|
2.59
|
|
5
|
Persistence and adherence with topical glaucoma therapy.
|
Am J Ophthalmol
|
2005
|
2.31
|
|
6
|
An application of propensity score matching using claims data.
|
Pharmacoepidemiol Drug Saf
|
2005
|
2.15
|
|
7
|
Paroxetine in the first trimester and the prevalence of congenital malformations.
|
Pharmacoepidemiol Drug Saf
|
2007
|
2.04
|
|
8
|
The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.
|
Chest
|
2005
|
2.04
|
|
9
|
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.
|
CMAJ
|
2002
|
1.99
|
|
10
|
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
|
Obstet Gynecol
|
2007
|
1.99
|
|
11
|
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
|
Obstet Gynecol
|
2007
|
1.87
|
|
12
|
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?
|
Arch Intern Med
|
2004
|
1.86
|
|
13
|
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
|
Clin Pharmacol Ther
|
2003
|
1.49
|
|
14
|
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
|
Pharmacoepidemiol Drug Saf
|
2012
|
1.46
|
|
15
|
Use of propensity score technique to account for exposure-related covariates: an example and lesson.
|
Med Care
|
2007
|
1.44
|
|
16
|
Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
|
Pharmacotherapy
|
2006
|
1.41
|
|
17
|
Effect of aprotinin on renal dysfunction.
|
Lancet
|
2008
|
1.39
|
|
18
|
The impact of wording in "Dear doctor" letters and in black box labels.
|
Clin Pharmacol Ther
|
2002
|
1.38
|
|
19
|
Analgesic use and change in kidney function in apparently healthy men.
|
Am J Kidney Dis
|
2003
|
1.37
|
|
20
|
Serious cardiovascular events and mortality among patients with schizophrenia.
|
J Nerv Ment Dis
|
2004
|
1.32
|
|
21
|
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction.
|
Am J Cardiol
|
2003
|
1.29
|
|
22
|
Occurrence of colon ischemia in relation to irritable bowel syndrome.
|
Am J Gastroenterol
|
2004
|
1.25
|
|
23
|
Coronary heart disease outcomes in patients receiving antidiabetic agents.
|
Pharmacoepidemiol Drug Saf
|
2007
|
1.25
|
|
24
|
Bupropion in pregnancy and the prevalence of congenital malformations.
|
Pharmacoepidemiol Drug Saf
|
2007
|
1.23
|
|
25
|
The urban spread of visceral leishmaniasis: clues from spatial analysis.
|
Epidemiology
|
2002
|
1.20
|
|
26
|
The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
|
Pharmacoepidemiol Drug Saf
|
2006
|
1.20
|
|
27
|
Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.
|
Pharmacoepidemiol Drug Saf
|
2002
|
1.16
|
|
28
|
Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population.
|
Pharmacoepidemiol Drug Saf
|
2006
|
1.09
|
|
29
|
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
|
Pharmacoepidemiol Drug Saf
|
2008
|
1.09
|
|
30
|
Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance.
|
J Clin Epidemiol
|
2002
|
1.07
|
|
31
|
Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia.
|
Clin Ther
|
2005
|
1.05
|
|
32
|
Severe vascular events in migraine patients.
|
Headache
|
2004
|
1.04
|
|
33
|
Dopamine antagonists and the development of breast cancer.
|
Arch Gen Psychiatry
|
2002
|
1.01
|
|
34
|
The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome.
|
Dig Dis Sci
|
2005
|
1.01
|
|
35
|
Identification of abacavir hypersensitivity reaction in health care claims data.
|
Pharmacoepidemiol Drug Saf
|
2007
|
0.95
|
|
36
|
Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride.
|
Am J Gastroenterol
|
2003
|
0.92
|
|
37
|
The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
|
Curr Drug Saf
|
2008
|
0.92
|
|
38
|
The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses.
|
Epilepsia
|
2007
|
0.92
|
|
39
|
Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
|
Epidemiology
|
2004
|
0.92
|
|
40
|
Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules.
|
Epidemiology
|
2012
|
0.91
|
|
41
|
Educational attainment and response to HAART during initial therapy for HIV-1 infection.
|
J Psychosom Res
|
2007
|
0.91
|
|
42
|
Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
|
Pharmacoepidemiol Drug Saf
|
2006
|
0.90
|
|
43
|
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
|
Contraception
|
2008
|
0.90
|
|
44
|
Studies of diabetes, thiazolidinediones, and coronary heart disease.
|
Pharmacoepidemiol Drug Saf
|
2007
|
0.88
|
|
45
|
A matched cohort study of the risk of cancer in users of becaplermin.
|
Adv Skin Wound Care
|
2011
|
0.88
|
|
46
|
Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation.
|
Pharmacoepidemiol Drug Saf
|
2006
|
0.88
|
|
47
|
Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
|
Med Care
|
2009
|
0.86
|
|
48
|
The effect of zanamivir treatment on influenza complications: a retrospective cohort study.
|
Clin Ther
|
2002
|
0.86
|
|
49
|
Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.
|
J Sex Med
|
2014
|
0.85
|
|
50
|
An event-based approach for comparing the performance of methods for prospective medical product monitoring.
|
Pharmacoepidemiol Drug Saf
|
2012
|
0.83
|
|
51
|
Comparison of resource utilization by patients treated with transdermal fentanyl and long-acting oral opioids for nonmalignant pain.
|
Pain Med
|
2002
|
0.81
|
|
52
|
Transarticular facet screw stabilization and dorsal laminectomy in 26 dogs with degenerative lumbosacral stenosis with instability.
|
Vet Surg
|
2012
|
0.81
|
|
53
|
Health care resource utilization in patients with active epilepsy.
|
Epilepsia
|
2009
|
0.81
|
|
54
|
Lung cancer and mesothelioma among male automobile mechanics: a review.
|
Rev Environ Health
|
2004
|
0.81
|
|
55
|
Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients.
|
Recent Results Cancer Res
|
2002
|
0.80
|
|
56
|
The long-term course of low-density lipoprotein cholesterol after initiation of statin treatment: retrospective database analysis over 3 years in health maintenance organization enrollees.
|
Clin Ther
|
2005
|
0.79
|
|
57
|
Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
|
Pharmacoepidemiol Drug Saf
|
2008
|
0.79
|
|
58
|
Determinants of the differences in LDL-cholesterol after initiation of statin treatment.
|
Ann Pharmacother
|
2005
|
0.79
|
|
59
|
Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
|
Transplantation
|
2005
|
0.78
|
|
60
|
Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: a retrospective study.
|
Clin Ther
|
2002
|
0.77
|
|
61
|
Asthma drug use and the development of Churg-Strauss syndrome (CSS).
|
Pharmacoepidemiol Drug Saf
|
2007
|
0.77
|
|
62
|
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.77
|
|
63
|
Characterizing vaccine-associated risks using cubic smoothing splines.
|
Am J Epidemiol
|
2012
|
0.77
|
|
64
|
Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
|
Contraception
|
2006
|
0.77
|
|
65
|
The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy.
|
Maturitas
|
2002
|
0.76
|
|
66
|
Corrigendum. Are airborne refractory ceramic fibers similar to asbestos in their carcinogenicity?
|
Inhal Toxicol
|
2012
|
0.75
|
|
67
|
The Zelnorm epidemiologic study (ZEST): a cohort study evaluating incidence of abdominal and pelvic surgery related to tegaserod treatment.
|
BMC Gastroenterol
|
2012
|
0.75
|
|
68
|
Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
|
Neurology
|
2007
|
0.75
|
|
69
|
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme.
|
Pharmacoepidemiol Drug Saf
|
2006
|
0.75
|
|
70
|
Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
|
Pharmacoepidemiol Drug Saf
|
2008
|
0.75
|